Category Pharmaceuticals and Biotech

Press Release -

Monopar Therapeutics and the Spanish Sarcoma Group (GEIS) Team Up on Phase 2 Sarcoma Trial With Monopar's Novel Camsirubicin

Trial Designed to Test Camsirubicin Against Doxorubicin as First-Line Therapy

Regis Technologies Now Offers Solid State Chemistry
Press Release -

Regis Technologies Now Offers Solid State Chemistry

Regis Technologies, a contract development and manufacturing organization for small molecule active pharmaceutical ingredients, announces a new Solid State Chemistry service.

Spherix Inc. (NasdaqCM: SPEX) Trading Below Book Value; Diversified Asset Base Adds Value
Press Release -

Spherix Inc. (NasdaqCM: SPEX) Trading Below Book Value; Diversified Asset Base Adds Value

Spherix's investment portfolio into emerging biotech stocks has resulted in substantial gains, turning a roughly $860,000 investment into a position worth more than $11 million at current share price levels, and marking a Price to Book ratio of less than 100%. The recently announced asset-purchase agreement of CBM BioPharma extends pipeline promise.

Bioz Launches the Next-Generation of Its Industry-Leading AI Search Engine for Life Science Experimentation
Press Release -

Bioz Launches the Next-Generation of Its Industry-Leading AI Search Engine for Life Science Experimentation

New AI Platform Accelerates Scientific Research and Drug Discovery, includes over 300 Million Product Listings from 50,000 Vendors

Florence Joins the Avoca Quality Consortium to Drive Technology Standardization Between Clinical Trial Sponsors and Sites
Press Release -

Florence Joins the Avoca Quality Consortium to Drive Technology Standardization Between Clinical Trial Sponsors and Sites

Florence today announced its membership in the Avoca Quality Consortium® (AQC) to drive technology adoption and standardization in order to reduce drug costs and development time.

Lotus Clinical Research Announces the Addition of Drs. Lee Simon and Allan Green
Press Release -

Lotus Clinical Research Announces the Addition of Drs. Lee Simon and Allan Green

Lotus Clinical Research Announces the Addition of Lee Simon, MD as Principal Advisor, Osteoarthritis Research and Allan Green, MD, PhD, JD as Medical Imaging and Research Advisor

2019 Genetic Testing Revenue to Cross $500 Mn With Rising Usage & Favoring Reimbursement
Press Release -

2019 Genetic Testing Revenue to Cross $500 Mn With Rising Usage & Favoring Reimbursement

Global clinical genomics market is expected to reach USD 879.0 million by 2023, at a CAGR of 17.1% during the forecast period of 2018 to 2023: Exclusive research by Meticulous Research®

Press Release -

$542,465 Failure to Warn Verdict in Pradaxa Blood Thinner Trial in Hartford, CT

Jury finds punitive damages warranted against Boehringer Ingelheim Pharmaceuticals, Inc.

Accelerating Development of Non-Opioid Pain Medicines
Press Release -

Accelerating Development of Non-Opioid Pain Medicines

Neil Singla, Chief Executive Officer of Lotus Clinical Research, Chaired the fourth annual American Pain Society Conference on Analgesic Trials (APS-CAT)